About

Rosalind is the former Lead Clinical Psychologist at Imperial College London’s Centre for Psychedelic Research. Her clinical team has been pioneering research in the therapeutic potential of psilocybin, particularly for depression and disconnection.

Rosalind has developed a psychedelic therapy model ‘Accept, Connect, Embody’, and a psychometric measure of ‘connectedness’ which her qualitative research identified as a mechanism of therapeutic change in psychedelic approaches. Collecting data from our participants, her research has recognised consistently positive outcomes for people attending Synthesis retreats. Rosalind will use her expertise to optimise the Synthesis retreat model, continue scientific research and develop a clinical model to help more people with mental illnesses in the future.

For more than three decades James has studied many of the world's perennial philosophies and engaged fully in a number of the great wisdom traditions, with specific interest in non-ordinary states of consciousness.

Trained formally in transpersonal psychotherapy and integral coaching and working with trauma and addiction, he is experienced at tracking tension and points of change and growth in individuals and groups. This unique experience allows him to fully understand the role of psychedelics and entheogens as a catalyst for authentic transformation.

Daan holds an MA in Spiritual Care and has years of professional experience working in mental health and addiction care. He is the co-founder of Guild of Guides Netherlands: an organisation that seeks to professionalize psychedelic sitting services. His experience with guiding and caring for people in altered states of consciousness spans over a decade; ranging from psychedelic harm reduction work on festivals to his private practice as a Psychedelic Chaplain.

Daan draws from his personal Buddhist practices, psychedelic research and his professional experiences to create compassionate and powerful containers for personal and relational transformation. As an avid explorer of consciousness, he is highly capable of supporting others who are traversing the landscapes of the mind.

Robin is the Head of the Centre for Psychedelic Research, in the Department of Brain Sciences at Imperial College London, where he has designed a number of functional brain imaging studies with psilocybin (magic mushrooms), LSD, MDMA (ecstasy) and DMT (ayahuasca), plus clinical trials of psilocybin for treatment-resistant depression. His scientific contributions to psychedelic-assisted therapy could play a significant role in the future of psychedelics for mental health care.

Robin states that scientific investigation into the therapeutic potential of psychedelics is vital for combating the mental health crisis. As a partner with the center, scientific research shows that the Synthesis experience was found to significantly reduce symptoms of anxiety and depression, improve sense of wellbeing and emotional stability, and increase connection to self, others and nature. Legal, professionally-organized retreats like Synthesis can be a safe way for people to experience the transformational potential of psychedelics, and they can also be a great source of data for research, helping to further advance the field. Robin works alongside Synthesis to provide high-quality services and meaningful scientific research for the psychedelic community.

Tero is the CEO and Founder of Four Sigmatic, a global superfood company helping people to elevate their wellness with adaptogenic mushroom ingredients. He is also the author of two best-selling books Healing Mushrooms and Santa Sold Shrooms.

A respected expert in the industry, Tero speaks at various events and was chosen twice as one of the world’s Top 50 Food Activists. Tero believes that professional, legal and modern contexts like Synthesis are making psychedelic experiences more accessible to help people gain the benefits of greater connection, personal healing and meaningful insights from a single dose.